Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy.

Abstract

Treatment-related complications contribute substantially to morbidity and mortality in acute myeloid leukemia (AML) patients undergoing induction chemotherapy. Although AML patients are susceptible to fluid overload (FO) (e.g., in the context of chemotherapy protocols, during sepsis treatment or to prevent tumor lysis syndrome), little attention has been paid to its role in AML patients undergoing induction chemotherapy. AML patients receiving induction chemotherapy between 2014 and 2019 were included in this study. FO was defined as ≥5% weight gain on day 7 of induction chemotherapy compared to baseline weight determined on the day of admission. We found FO in 23 (12%) of 187 AML patients undergoing induction chemotherapy. Application of >100 ml crystalloid fluids/kg body weight until day 7 of induction chemotherapy was identified as an independent risk factor for FO. AML patients with FO suffered from a significantly increased 90-day mortality rate and FO was demonstrated as an independent risk factor for 90-day mortality. Our data suggests an individualized, weight-adjusted calculation of crystalloid fluids in order to prevent FO-related morbidity and mortality in AML patients during induction chemotherapy. Prospective trials are required to determine the adequate fluid management in this patient population.

• Authors: Olivier Ballo, Fagr Eladly, Sebastian Koschade, Stefan Büttner, Jan Alexander Stratmann, Uta Brunnberg, Eva-Maria Kreisel, Franziska Frank, Sebastian Wagner, Björn Steffen, Hubert Serve, Fabian Finkelmeier, Christian H Brandts
• Journal: Annals of hematology (Ann Hematol) Vol. 100 Issue 10 Pg. 2603-2611 (Oct 2021) ISSN: 1432-0584 [Electronic] Germany
• PMID: 34304288 (Publication Type: Journal Article)
• Copyright: © 2021. The Author(s).

Topics

• Adult
• Aged
• Female
• Humans
• Induction Chemotherapy (adverse effects)
• Leukemia, Myeloid, Acute (mortality, therapy)
• Male
• Middle Aged
• Prospective Studies
• Retrospective Studies
• Risk Factors
• Young Adult